<DOC>
	<DOCNO>NCT00589706</DOCNO>
	<brief_summary>data wistar institute indicated anti-body label iodine-125 would localize tumor cell high grade glioma brain . project combine surgery , radiation therapy , chemotherapy label antibody prospective phase II trial disease entity .</brief_summary>
	<brief_title>A Phase II Study Adjuvant Use Anti-Epidermal Growth Factor Receptor EGFR-425 High Grade Gliomas</brief_title>
	<detailed_description />
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>case 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>high grade glioma brain</keyword>
	<keyword>anti-body treatment</keyword>
	<keyword>survival</keyword>
</DOC>